Raily Aesthetic Medicine International Holdings Limited
HKEX:2135.HK
0.11 (HKD) • At close September 13, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 189.384 | 164.522 | 188.367 | 164.545 | 191.156 | 158.935 | 112.932 |
| Kosten van de omzet
| 117.891 | 97.739 | 118.675 | 84.374 | 90.118 | 66.442 | 38.39 |
| Brutowinst
| 71.493 | 66.783 | 69.692 | 80.171 | 101.038 | 92.493 | 74.542 |
| Brutowinstmarge
| 0.378 | 0.406 | 0.37 | 0.487 | 0.529 | 0.582 | 0.66 |
| Onderzoek- en ontwikkelingskosten
| 1.602 | 2 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 40.1 | 35.882 | 34.724 | 36.971 | 19.902 | 6.295 | 2.722 |
| Verkoop- en marketingkosten
| 52.285 | 49.287 | 54.533 | 33.133 | 50.172 | 44.667 | 37.02 |
| Verkoop-, algemene en administratieve kosten
| 92.385 | 85.169 | 89.257 | 70.104 | 70.074 | 50.962 | 39.742 |
| Overige kosten
| 0 | -2.345 | -2.327 | -0.859 | -0.287 | -0.22 | -0.446 |
| Bedrijfskosten
| 104.54 | 86.948 | 88.976 | 66.859 | 83.577 | 63.156 | 49.412 |
| Bedrijfsresultaat
| -22.494 | -19.439 | -20.775 | 12.627 | 17.998 | 29.15 | 24.693 |
| Bedrijfsresultaat ratio
| -0.119 | -0.118 | -0.11 | 0.077 | 0.094 | 0.183 | 0.219 |
| Totaal overige inkomsten en kosten netto
| -12.516 | -2.662 | -2.173 | -1.06 | -1.61 | -2.767 | -1.361 |
| Inkomen voor belasting
| -35.01 | -22.101 | -22.948 | 11.567 | 16.388 | 26.383 | 23.332 |
| Inkomen voor belasting ratio
| -0.185 | -0.134 | -0.122 | 0.07 | 0.086 | 0.166 | 0.207 |
| Belastingkosten
| 2.769 | -1.854 | -4.682 | 6.656 | 6.111 | 7.965 | 5.927 |
| Nettowinst
| -32.457 | -15.911 | -17.691 | 4.251 | 9.897 | 17.855 | 17.379 |
| Nettowinstmarge
| -0.171 | -0.097 | -0.094 | 0.026 | 0.052 | 0.112 | 0.154 |
| WPA (Winst Per Aandeel)
| -0.078 | -0.008 | -0.009 | 0.003 | 0.005 | 0.009 | 0.009 |
| Verwaterde WPA
| -0.078 | -0.008 | -0.009 | 0.003 | 0.005 | 0.009 | 0.009 |
| EBITDA
| -6.996 | 3.754 | -6.247 | 25.955 | 29.751 | 37.698 | 32.201 |
| EBITDA ratio
| -0.037 | 0.023 | -0.033 | 0.158 | 0.156 | 0.237 | 0.285 |